Uzbekistan to participate in clinical trial of Chinese anti-COVID-19 drug candidate
AKIPRESS.COM - Two Chinese antiviral medicine for COVID-19 mainly developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences (CAS) have commenced human trials overseas, Xinhua reported...